Long term goals. Our goals are to understand the mechanisms that regulate the concentrations of the endogenous ligands of the brain cannabinoid receptor (CB1) available to activate the receptor. This is important because of the importance of CB1 receptor activation in the regulation of signaling in the brain. Hypothesis: We hypothesize that changes in neuronal activity induce a rapid redistribution of the endocannabinoids (eCBs) from intracellular to extracellular domains. We further hypothesize that this redistribution occurs as a result of a combination of the mobilization of the eCBs from intracellular sequestration sites, increased synthesis and reduced catabolism. We also hypothesize that the primary sites of eCB catabolism are presynaptic, CB1 receptor expressing neurons.
Aims :
Our first aim i s to determine regulation of eCB release in response to increased synaptic activity;the second is to study the mechanisms of inactivation of 2-AG;
the third aim i s to determine whether sterol carrier protein 2 is involved in the accumulation or sequestration of the eCBs by neurons. Methods: We will carry out these studies using cells in culture and cerebellar slices. We will use liquid chromatography:mass spectrometry to measure the effects of neuronal activation on the redistribution of the eCBs between tissue and buffer. Significance: It is becoming increasingly clear that the eCB/CB1 signaling pair plays important roles in many behavioral and neuropsychiatric disorders. In particular, several studies in both animals and humans suggest that altered eCB production could enhance the addictive liability of drugs of abuse. A CB1 receptor antagonist is being considered as a therapy for smoking cessation, for example. Therefore, increased understanding of the processes involved in the endogenous activation of the CB1 receptor will aid in our understanding of the potential for this drug to treat addiction. Novelty: Our laboratory has focused on the use of liquid chromatography mass spectrometry to assay endocannabinoids. We have coupled this technique with our ability to culture cells from the cerebellum as a unique approach to these goals.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
3R01DA009155-12S1
Application #
7925217
Study Section
Molecular Neuropharmacology and Signaling Study Section (MNPS)
Program Officer
Purohit, Vishnudutt
Project Start
2009-09-30
Project End
2011-09-29
Budget Start
2009-09-30
Budget End
2011-09-29
Support Year
12
Fiscal Year
2009
Total Cost
$167,200
Indirect Cost
Name
Medical College of Wisconsin
Department
Pharmacology
Type
Schools of Medicine
DUNS #
937639060
City
Milwaukee
State
WI
Country
United States
Zip Code
53226
Nithipatikom, Kasem; Endsley, Michael P; Pfeiffer, Adam W et al. (2014) A novel activity of microsomal epoxide hydrolase: metabolism of the endocannabinoid 2-arachidonoylglycerol. J Lipid Res 55:2093-102
Liedhegner, Elizabeth Sabens; Vogt, Caleb D; Sem, Daniel S et al. (2014) Sterol carrier protein-2: binding protein for endocannabinoids. Mol Neurobiol 50:149-58
Liedhegner, Elizabeth Sabens; Sasman, Amy; Hillard, Cecilia J (2014) Brain region-specific changes in N-acylethanolamine contents with time of day. J Neurochem 128:491-506
Lee, Tiffany T-Y; Hill, Matthew N; Hillard, Cecilia J et al. (2013) Temporal changes in N-acylethanolamine content and metabolism throughout the peri-adolescent period. Synapse 67:4-10
Hill, M N; Kumar, S A; Filipski, S B et al. (2013) Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure. Mol Psychiatry 18:1125-35
Klein, Carolin; Hill, Matthew N; Chang, Sabrina C H et al. (2012) Circulating endocannabinoid concentrations and sexual arousal in women. J Sex Med 9:1588-601
Hillard, C J; Weinlander, K M; Stuhr, K L (2012) Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence. Neuroscience 204:207-29
Wang, Meina; Hill, Matthew N; Zhang, Longhua et al. (2012) Acute restraint stress enhances hippocampal endocannabinoid function via glucocorticoid receptor activation. J Psychopharmacol 26:56-70
Roberts, C J; Stuhr, K L; Hillard, C J (2012) Swim stress differentially affects limbic contents of 2-arachidonoylglycerol and 2-oleoylglycerol. Neuroscience 204:74-82
Vaughn, L K; Mantsch, J R; Vranjkovic, O et al. (2012) Cannabinoid receptor involvement in stress-induced cocaine reinstatement: potential interaction with noradrenergic pathways. Neuroscience 204:117-24

Showing the most recent 10 out of 73 publications